55 related articles for article (PubMed ID: 454971)
1. The use of ADTN (2-amino-6,7-dihydroxy-1,2,3,4-tetrahydronaphthalene) as a ligand for brain dopamine receptors [proceedings].
Cross AJ; Crow TJ; Owen F
Br J Pharmacol; 1979 May; 66(1):87P. PubMed ID: 454971
[No Abstract] [Full Text] [Related]
2. [3H] 2-Amino-6,7-dihydroxy 1,2,3,4-tetrahydronapthalene (ADTN): a potential specific dopamine receptor ligand.
Clement-Cormier Y; Abel M
Res Commun Chem Pathol Pharmacol; 1978 Oct; 22(1):15-25. PubMed ID: 725314
[TBL] [Abstract][Full Text] [Related]
3. ADTN (2-amino-6,7-dihydroxy-1,2,3,4-tetrahydronaphthalene): a prototype for possible dopaminergic false transmitters?
Roberts PJ; Davis A
Adv Biochem Psychopharmacol; 1978; 19():177-91. PubMed ID: 696460
[No Abstract] [Full Text] [Related]
4. Stereospecific binding of 2-amino-6,7-dihydroxy-1,2,3,4-tetrahydronaphthalene to rat brain dopamine receptors [proceedings].
Davis A; Poat JA; Woodruff GN
Biochem Soc Trans; 1979 Feb; 7(1):147-8. PubMed ID: 437261
[No Abstract] [Full Text] [Related]
5. Binding of a conformationally restricted dopamine analogue, 2-amino-6,7-dihydroxy-1,2,3,4-tetrahydronaphthalene, to receptors on rat brain synaptic membranes.
Roberts PJ; Woodruff GN; Poat JA
Mol Pharmacol; 1977 May; 13(3):541-7. PubMed ID: 17829
[No Abstract] [Full Text] [Related]
6. Selective storage in vivo of 5,6-ADTN in dopamine-rich areas of the rat brain.
Westerink BH; Dijkstra D; Feenstra MG; Horn AS; Rollema H
Eur J Pharmacol; 1980 Jun; 64(2-3):115-21. PubMed ID: 7398758
[TBL] [Abstract][Full Text] [Related]
7. Dopamine receptor binding of 3H-ADTN (2-amino-6,7-dihydroxy-1,2,3,4-tetrahydronaphthalene) regulated by guanyl nucleotides.
Creese I; Snyder SH
Eur J Pharmacol; 1978 Aug; 50(4):459-61. PubMed ID: 699970
[No Abstract] [Full Text] [Related]
8. Uptake of 2-amino-6,7-dihydroxy-1,2,3,4-tetrahydronaphthalene (ADTN) into rat brain synaptosomes [proceedings].
Davis A; Roberts PJ; Woodruff GN
Br J Pharmacol; 1977 Nov; 61(3):478P-479P. PubMed ID: 588829
[No Abstract] [Full Text] [Related]
9. Effects of ADTN and various other 2-aminotetralin derivatives on the efflux of 3H-dopamine from rat striatal slices.
Mulder AH; Braakhuis B; De Regt V; Dijkstra D; Horn AS
Eur J Pharmacol; 1980 Jun; 64(4):349-55. PubMed ID: 7389827
[TBL] [Abstract][Full Text] [Related]
10. The use of R(+)-ADTN in dopamine receptor binding assays.
Davis A; Poat JA; Woodruff GN
Eur J Pharmacol; 1980 May; 63(2-3):237-8. PubMed ID: 6155278
[No Abstract] [Full Text] [Related]
11. Binding of 2-amino-6,7-dihydroxy-1,2,3,4-tetrahydronaphthalene to rat brain synaptic membranes: association with the dopamine (3,4-dihydroxyphenethylamine) receptor.
Roberts PJ; Woodruff GN; Poat JA
Biochem Soc Trans; 1976; 4(2):316-7. PubMed ID: 1001677
[No Abstract] [Full Text] [Related]
12. Dopamine receptor binding regulated by guanine nucleotides.
Creese I; Usdin TB; Snyder SH
Mol Pharmacol; 1979 Jul; 16(1):69-76. PubMed ID: 481426
[No Abstract] [Full Text] [Related]
13. The significance of COMT activity in controlling dopamine agonist levels in brain and serum: studies with a prodrug and a metabolite of 6,7-ADTN.
Rollema H; Westerink BH; Mulder TB; Dijkstra D; Feenstra MG; Horn AS
Eur J Pharmacol; 1980 Jun; 64(4):313-23. PubMed ID: 7389825
[TBL] [Abstract][Full Text] [Related]
14. Effects of the (+) and (-)-enantiomers of 2-amino-6,7-dihydroxy-1,2,3,4-tetrahydronaphthalene on dopamine receptors and on dopamine uptake [proceedings].
Andrews CD; Davis A; Freeman HS; McDermed JD; Poat JA; Woodruff GN
Br J Pharmacol; 1978 Nov; 64(3):433P. PubMed ID: 719283
[No Abstract] [Full Text] [Related]
15. Binding of [3H]amino-6,7-dihydroxy-1,2,3,4-tetrahydronaphthalene to rat striatal membranes. Effects of purine nucleotides and ultraviolet irradiation.
Zahniser NR; Heidenreich KA; Molinoff PB
Mol Pharmacol; 1981 May; 19(3):372-8. PubMed ID: 7266464
[No Abstract] [Full Text] [Related]
16. [3H]2-amino-6,7-dihydroxy-1,2,3,4-tetrahydronaphthalen (ADTN). Regional distribution and in vivo binding after acute and chronic drug treatment.
Clement-Cormier Y; Smith CE
Neurochem Res; 1980 Jun; 5(6):641-51. PubMed ID: 7402434
[TBL] [Abstract][Full Text] [Related]
17. Lack of effects of fibrinogen degradation products on specific binding of [3H]spiroperidol and [3H]ADTN.
Buczko W; De Blasi A
Pol J Pharmacol Pharm; 1983; 35(1):45-7. PubMed ID: 6889186
[TBL] [Abstract][Full Text] [Related]
18. A prodrug of ADTN: selectivity of dopaminergic action and brain levels of ADTN.
Horn AS; Kelly P; Westerink BH; Dijkstra D
Eur J Pharmacol; 1979 Nov; 60(1):95-9. PubMed ID: 574829
[TBL] [Abstract][Full Text] [Related]
19. Differential effects of ascorbate and EDTA on high-affinity binding of 3H-apomorphine and 3H-ADTN to calf caudate membranes.
Arana GW; Baldessarini RJ; Kula NS
Neuropharmacology; 1982 Jun; 21(6):601-4. PubMed ID: 6810198
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and biological evaluation of analogues of Pro-Leu-Gly-NH2 modified at the leucyl residue.
Johnson RL; Bontems RJ; Yang KE; Mishra RK
J Med Chem; 1990 Jun; 33(6):1828-32. PubMed ID: 1971310
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
